{
    "code": "52028057",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028057",
    "time": "2022-03-11 05:19:05",
    "許可證字號": "衛部藥輸字第028057號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/03\/29",
    "發證\/登錄日期": "110\/03\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202805702",
    "中文品名": "多受祿凍晶注射劑",
    "英文品名": "Doxorubicin Mylan Lyophilized Powder for Injection",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "10毫克、50毫克小瓶裝 每盒100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "一般學名藥",
    "監視期限": "",
    "主成分略述": "DOXORUBICIN HYDROCHLORIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "6201118216  台灣邁蘭有限公司",
    "申請商地址": "臺北市信義區信義路５段7號27樓",
    "主製造廠": [
        {
            "": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000620",
            "成分名稱": "DOXORUBICIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "0.0100000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1003000620",
            "成分名稱": "DOXORUBICIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "0.0500000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "Doxorubicin 中文仿單_202106009-110-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028057&Seq=001&Type=9"
        },
        {
            "title": "Doxorubicin HCL Inj _vial - 1's Artworks - Taiwan-110-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028057&Seq=001&Type=8"
        }
    ]
}